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Summary.-Human peripheral-blood mononuclear cells, separated by Isopaque-
Ficoll flotation and E-rosette formation, were tested by the fluorescein fluorescence
polarization method of Cercek & Cercek (the SCM test). The response to stimulation
with PHA or cancer tissue leads to a decreased polarization value (P). The responding
cells were present in the T-cell fraction (E-rosette-forming cells), which contained
less than 10% macrophages and less than 1% cells with surface-bound Ig. Control
experiments with the non-T-cell fraction gave different response patterns.
The response of T cells from apparently healthy donors and patients with and
without cancer were compared. All of the group of 16 healthy persons had a polariza-
tion value (P) which decreased (mean+ s.e. =23 0 ±2) after PHA stimulation, com-
pared with no or little decrease after stimulation with cancer tissue, giving cancer
indices(Pcancer/PPHA) of 1. 15-156. In 13patients withcarcinoma ofthe colon, stimula-
tion with PHA produced little decrease of polarization, while stimulation with colonic
cancer tissue decreased the polarization in all cases (mean + s.e.=25% +2). The
corresponding cancer indices were 0.61-0-86.
Seven of 10 colonic-cancer patients tested against ovarian cancer tissue did not
respond, whilst 3 patients in this group responded andhad a cancer index less than1-0.
Three patients with non-malignant diseases had response patterns similar to those
of healthy persons, except for the lack of PHA response in the patient with ulcerative
colitis. This method seems to open up new possibilities for evaluation of cancer
patients, although further studies including many more patients are needed before
any conclusion can be drawn as to the validity of the test.
FLUORESCENCE POLARIZATION TECH-
NIQUES are used to determine micro-
viscosity or structuredness of the cyto-
plasmic matrix (SCM) of living cells.
Cercek & Cercek have applied this method
to the study of changes in the SCM occur-
ring in the human lymphocytes after
stimulation with phytohaemagglutinin
(PHA), cancer basic protein (CaBP) or
cancer-tissue-associated antigens (Cercek
& Cercek, 1974; Cercek et al., 1977). They
found decreased polarization after PHA
stimulation of lymphocytes from healthy
donors and patients with non-malignant
diseases, but not from cancer patients. On
the other hand, cancer basic protein and
tumour tissue-associated antigens decrea-
sed the polarization in cancer patients, but
not in non-cancer persons (Cercek &
Cercek, 1977). When a certain type of can-
certissue was usedin the test, the response
seemedtobespecificforthis type ofcancer,
and positive responses also seemed to be
related to treatment or the presence of
tumour cells in the patients (Cercek &
Cercek, 1975a, b).
Therefore this test system could be a
valuable adjunct in diagnosis ofmalignant
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diseases and possibly also in the manage-
ment of cancer treatment. However, the
SCM test has been difficult to reproduce in
many laboratories (Bagshawe, 1977), and
only recently have other groups been able
to confirm the test. One of the problems is
that the responding cells are not well
defined, and the procedures which have
been used for separation of blood cells do
not differentiate between various cell
types such as T and B lymphocytes. We
have used T lymphocytes as responder
cells in the test, and report our preliminary
results with this modification of the SCM
test.
MATERIALS AND METHODS
We have tested 18 samples from appareiitlv
healthy persons and 18 samples from patients.
Fourteen ofthe patients had adenocarcinoma
of the colon or rectum, confirmed histologic-
ally or by surgery, one had carcinoma of the
pancreas and 3 patients had non-malignant
disease when tested (Table IV). The blood
samples were collected in Vacutainer tubes
containing sodium heparin. The separation of
lymphocytes started within a few hours and
the test was completed within 30 h or less.
Preparation of T and non-T cells-This
was done by the ordinary E-rosetting tech-
nique. Fifteen ml of heparinized blood were
diluted with an equal amount of sterile saline
and the lymphocytes separated by the
Isopaque-Ficoll flotation technique, density
1-077 g/ml ("Lymphoprep", Nyegaard & Co.,
Oslo, Norway) (Boyum, 1975). Centrifuga-
tion was done at room temperature (400 g
for 30 min), the white-cell layer removed and
divided into 2 tubes and washed twice in
Medium RPMI 1640. To each tube was added
4 ml of RPMI 1640 containing 20% heat-
inactivated foetal bovine serum and 4 ml of
1% sheep red cells (SRBC) also suspended in
this medium. The tubes were incubated at
37°C for 15 min, centrifuged at 200 g for 5 min
and, in most experiments, kept overnight at
40C.
The sediment (E rosettes) was then gently
resuspended in its own supernatant, the con-
tent transferred into 2 other tubes each con-
taining 3 ml ofLymphoprep solution, and the
Isopaque-Ficoll procedure was repeated. The
floating cell layer was removed and the cells
washed twice in phosphate-buffered saline
(PBS). These cells were called non-T cells and
used in control experiments in concentrations
of 4-5 x 106/ml. The sediment, containing the
E-rosette-forming cells, was resuspended in
the autologous plasma, which was cell-free
and diluted 1/2 in saline. In most cases the
sheep red cells were lysed by the human xeno-
antibodies after incubation at 37°C for 15-20
min. If sheep erythrocytes still remained, the
lysis was completed by treatment with dis-
tilled water for 40 sec (Walford et al., 1965).
The human lymphocytes, which resist this
treatment, were washed twice in PBS and
used in our experiments as the T-cell fraction,
in concentrations of 4-5 x 106/ml.
The T-cell fraction was further studied to
detect contamination with macrophages and
B cells. Ten such fractions from healthy
dohors and cancer patients were tested by the
peroxidase staining procedure or the latex
digestion method (Albrechtsen & Lied, 1978;
Kaplow, 1965) to identify macrophages, and
the direct immunofluorescence technique
with FITC labelled F(ab')2 goat anti-human
total immunoglobulin (Kallestad, Chasks,
Minn., U.S.A., Lot 141H028-3) was used to
detect non-phagocytozing cells with surface
immunoglobulin (B cells). The count of
peroxidase-positive cells was 6% + 0 75, and
there was less than 1% Ig+ cells (Table I).
The ratio of peroxidase-positive cells in the
non-T suspensions was more than 10 x
higher (63.7% ± 2-5). The ratio of B cells was
not further studied in this suspension.
PHA, reagent grade (Lot K 4141, Well-
come) diluted 1/5 after reconstitution, was
used as stimulating agent. Aliquots of 50 ,ul
of the diluted PHA were incubated with
0 5 ml ofthe cell suspension at 37°C for 40-45
min. Similar experiments weredone in parallel
with histologically defined tumour tissue as
stimulating agent (Cercek & Cercek, 1975b,
1977). We used two resection specimens; one
was a colonic adenocarcinoma and the other
a poorly differentiated serous adenocarcinoma
of the ovary. The tumour specimens were
frozen at -25°C within 4 h of removal, and
cut into pieces of , 10-20 mm3 which were
kept frozen until use. A piece oftumour tissue
was then thawed at room temperature,
washed x 5 in PBS and heated in this buffer
at 56°C for 15 min to inactivate enzymes.
After inactivation, the tube with tumour
tissue was cooled to 37°C, mixed with 0-5 ml
of the cell suspension and incubated at 37°C
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for 15 min. During incubation the tube was
stirred 2-3 times.
Fluorescein diacetate, pure R.A. (Koch-
Light Ltd, Batch 74145) was recrystallized
twice in acetic anhydride, as recommended
by Cercek & Cercek (personal communica-
tion), and dissolved in Aristar grade glacial
acetic acid to prepare the fluorescein diace-
tate (FDA) stock solution (Cercek & Cercek,
1977). We used a Perkin-Elmer MPF 44
fluorescence spectrophotometer equipped
with polarization and recording accessories
ofhigh quality.
The SCM, expressed as polarization value
P, was measured by the intracellular fluores-
cence polarization method ofCercek & Cercek
(1977; Cercek et al., 1974). The reponse ratio,
RR, which is the P value after stimulation
with cancer tissue divided by the P value
for PHA-stimulated cells, was calculated and
used as a cancer index. The different P values
determined in each sample (Po, PPHA, PCCT
and POCT) were obtained from the same cell
suspension. Evaluation of the recording pat-
terns'and calculation of P values were done
"half blind", i.e. without knowledge of which
experiment was on the chart. In four of the
patients the diagnosis also wasunknown when
the test was performed.
Statistics.-The mean and standard error
(s.e.) were calculated and given for P values,
% decrease ofP values, and cancer indices in
each group.
RESULTS
The cell fractions used as responder cells
were characterized as in Table I. The E-
TABLE I.-Occurrence of non-E rosette-
forming cells (non-T cells) in our respond-
ing T-cell suspension
Per-
Sample oxidase+
No. %
1
2
3
4
5
6
7
8
9
10
Mean+ s.e. mean
* Digesting cells.
Not tested.
4
5
5
4
9
5
9
10
4*
5*
Ig+
<1
<1I
<1I
<1
< 1
<1
< 1
< I
6+0-75 <1
rosette-forming T-cell fraction had < 10%
peroxidase-positive cells, and the concen-
tration of cells with surface Ig was <1%.
The fraction which did not form E
rosettes had 48-76% peroxidase-positive
cells. The concentration of cells with
surface Ig was not further studied in this
fraction, which was used in our pre-
liminary experiments only.
Preliminary experiments showed that
the non-T cell fraction did not respond to
PHA or cancer tissue with decrease in P
(Table II). In most cases P actually
increased.
TABLE II.-Intracellular fluorescence
polarization before (PO) and after in
vitro stimulation with PHA (PPHA) and
colonic cancer tissue (PCCT) in non-T
lymphocytes
1.
2.
3.
4.
5.
ME
S.(
Diagnosis Po PPHA
Normal 0-163 04177
,11, 0-155 0-190
0-208 0-208
Carcinoma of
the rectum 0-159
,,, 0-175
ean 0-172 0-192
e. 0.010 0009
De-
crease
(-9)
(-23)
(0)
PCCT
0*174
0-200
De-
crease
(-6)
(-29)
0-179 (- 13)
0-241 (-38)
0-199
0-015
- Not tested.
Experiments with the T-cell fraction
are shown in Tables III and IV. In appar-
ently healthy persons the polarization
decreased after PHA stimulation, with no
or little decrease after stimulation with
colonic cancer tissue. The corresponding
cancer indices were 1-15-1-56. In the group
ofpatients with colonic cancer P decreased
25% after stimulation with colonic-cancer
tissue, as compared to 4% after stimula-
tion with PHA. Stimulation with tissue
from cancer ofthe ovary gave comparable
results with PHA, except in 2 cases show-
ing decreased values and 2 cases in which
the values increased. In the patient with
pancreatic cancer, no significant decrease
of P was seen after stimulation with PHA
or colonic-cancer tissue, but a 20% de-
crease was seen after incubation with
ovarian cancer tissue. The patient with
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TABLE III.-Intracellular fluorescence polarization values of T-cellfractions before (Po),
and after in vitro stimulation with phytohaemagglutinin (PPHA) and colonic cancer
tissue (PCCT)
Apparently
healthy
persons Decrease
No. PO PPHA %
1 0 202 0-152 (25)
2 0-205 0-139 (32)
3 0-208 0*157 (25)
4 0-192 0-152 (21)
5 04199 0-150 (25)
6 0*190 0-139 (27)
7 0-188 0-147 (22)
8 0*197 0-158 (20)
9 0-192 0-148 (23)
10 0-211 0-131 (38)
11 0-184 0-158 (14)
12 0-181 0-150 (17)
13 0-183 0*149 (19)
14 0-233 0-154 (34)
15 0*199 0-171 (14)
16 0-198 0*165 (17)
Mean 04198 04151 (23)
S.e. 0 003 0 003 (2)
No. 9
retested 0-213 0-167 (22)
No. 4
retested 0*166 0-115 (31)
Cancer index
Decrease RRCCT PCCT
PCCT % PPHA
0*188 (5) 1*18
0-200 (5) 1-53
0-183 (1) 1-15
0-174 (4) 1-16
0-187 (- 2) 1-25
0-195 (16) 1-26
0*226 (-14) 1-32
0-219 (- 11) 1*32
0X197 (0-5) 1X27
0*006 (3) 0-04
0*197 (8) 1*17
0X180 (-8) 1-56
- Not tested.
TABLE IV.-Intracellular fluorescence polarization values of T-cellfrcactions before (PO),
and after in vitro stimulation with PHA (PPHA), colonic cancer tissue (PCCT) and
ovarian cancer tissue (POCT)
Decrease
Diagnosis Po PPHA %
1. Carcinoma of
the colon 0-163 0-154 (6)
2. ,, ,, 0-234
3.,,,, 0-179 0-174 (3)
4. ,, ,, 0-187 0-173 (7)
5. ,, ,, 0187 0*179 (4)
6. , ,, 0-179 0-170 (5)
7. ,,,, - 0252
8. ,,,, 0-184 0-173 (6)
9.,,,, 0-182 0-173 (5)
10. ,,,, 0-181 0-181 (0)
11. ,,,, 0195 0-184 (6)
12. ,,,, 0191 0-202 (-6)
13. ,, ,, 0.219 0 202 (8)
14. ,, ,, 0-172 0*172 (0)
Mean 0-189 0-184 (4)
S.e. 0 005 0-007 (1)
15. Carcinoma of
the pancreas 0-173 0-169 (2)
16. Ulcerative
colitis 0-171 0-184 (-8)
17. Pancreatitis,
diabetes,
gastritis 0-186 0-139 (25)
18. Dyspepsia 0-180 0 158 (12)
Decrease
PCCT %
0*133 (43)
0-134 (25)
0-131 (30)
0*130 (30)
0-122 (32)
0-156
0-148 (20)
0-132 (27)
0-156 (14)
0-158 (19)
0-160 (16)
0 157 (28)
0*136 (21)
0-143 (25)
0-004 (2)
0-164 (5)
0-188 (- 10)
0*187 (-1)
0*181 (-1)
Cancer index
Decrease -_A._-
POCT % RRCCT RROCT
0*185 (1)
0-179 (4)
0-153 (15)
0-236
0*211 (- 15)
0-179 (2)
0-187 (4)
0-161 (16)
0-218 (0, 5)
0-190 (- 10)
0-190 (2)
0-008 (3)
0*139 (20)
0-172 (- 1)
0*184 (1)
0-178 (1)
0 77
0-75 1-06
0*72 1.00
0-71 0 90
0-61 0-93
0-85 1-21
0-76 1-03
0-86
0-85 1.01
0-79 0 80
0-77 1-08
0*79 1.10
0-77 1.01
0-02 0-03
0*97 0*82
1-02 0 93
1-34 1-32
1*14 1-13
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chronic pancreatitis, diabetes and gastritis
had a response pattern which is compar-
able with those from healthy persons. The
same pattern was found in another patient
with dyspepsia without evidence of malig-
nant disease. The patient with ulcerative
colitis had no response either to PHA or
cancer tissue. The ability of this test
system to discriminate between patients
with and without colonic cancer is best
demonstrated by calculating the response
ratio or cancer index, which was 0-61-0-86
for patients with colonic cancer compared
to 0-97-1 56 for persons without (Tables
III-IV). The control with tissue from
ovarian cancer in most cases showed RR
ratios above 1P0.
DISCUSSION
The T-cell fraction consists of cells with
receptors for sheep erythrocytes (i.e.
mainly T lymphocytes), whilst the domi-
nant cells in the non-T-cell fraction were
peroxidase-positive monocytes or macro-
phages. The non-T cell fraction had a
mean P 13% lower than the responding
T-cell fraction. When stimulated with
PHA or cancer tissue, the P values of the
non-T cells increased, in contrast to the
decrease seen with the T-cell fraction.
Although the number of experiments with
non-T cells was few, our results indicate
that it is essential to use T lymphocytes in
this test system. Unsuccessful trials with
the SCM method could in part be due to
poor separation of T from non-T cells,
which is obtained by iron-powder treat-
ment and gradient centrifugation. The
separation procedure of Cercek & Cercek
(1977) gave inconsistent results in our
hands. The procedure seems to be very
sensitive, even for minor divergencies in
the test condition, and the removal of re-
sponder cells from the top layer without
admixture of non-responding cells was
technically difficult. We had few technical
problems using T lymphocytes which had
been purified byrosetting. Cercek & Cercek
(1977) have found up to 60-70% T lym-
phocytes in the responding cell fraction,
and it is likely that the responding cells in
their assay actually were T or mainly T
lymphocytes. However, it still remains to
show whether the B lymphocytes have a
role in the SCM assay.
Sedimentation of T lymphocytes by
sheep red cells, and shock treatment with
distilled water did not seem to affect the
ability of the cell to respond either to
PHA or to cancer tissue.
The mean fluorescence polarization
values of T lymphocytes, which were
0-198 + 0 003 for healthy persons and
0-189 + 0 005 for cancer patients compare
well with the SCM values found by Cercek
et al. (1974, 1975b, 1977). Also, the good
differentiation between healthy persons
and patients with non-malignant diseases
on one hand, and cancer patients on the
other agrees well with the observations of
the other groups (Cercek & Cercek, 1977;
Kreutzmann et al., 1978; Pritchard et al.,
1978; Takaku etal., 1977). The decrease of
polarization after stimulation with PHA
and cancer tissue was of the same order
and similar to the reported findings.
In our study, the lymphocytes fro 7/lOm
colonic cancer patients which were tested
against ovarian cancer tissue did not
respond, as expected from the previous
finding of Cercek & Cercek (1975b). How-
ever, in 3 other patients the T lympho-
cytes responded to ovarian cancer as well
as to colonic cancer tissue. This could
possibly mean that the 2 types of cancer
had common antigenic sites, but these
problems will need further evaluation.
In Case No. 15 colonic cancer was diag-
nosed when the test was performed, but
later the diagnosis turned out to be pan-
creatic carcinoma. We found no response
to colonic cancer tissue, but a 20% de-
crease of P after stimulation with tissue
from cancer ofthe ovary. This patient was
a man, and the response could possibly
indicate another example of a cross-
reaction.
The patient with ulcerative colitis, who
showed no response either to colonic
cancer tissue or to PHA, may represent a
special premalignant group (Cercek &
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Cercek, 1975a), although further work will
be necessary to establish such criteria.
The test was repeated some weeks after-
wards with the same result. Clinically
there was no evidence of malignancy. In
the 2 other cases with non-malignant
diseases, the response was similar to that
found in apparently healthy persons,
which is in good accordance with the
observations of Cercek & Cercek (1977).
CONCLUSIONS
Our observations indicate that the cells
which respond in the SCM test are T
lymphocytes. Our method for separation
of lymphocytes differs from that reported
by the Cerceks, but we have confirmed the
observations that it may be possible by the
SCM test to differentiate between persons
with and without malignant disease,
although further investigations are neces-
sary to evaluate the clinical validity ofthe
test. In our study, few patients with non-
malignant disorders were included. It is
important to do more extensive studies,
particularly in patients with ulcerative
colitis or in other diseases which possibly
involve immune mechanisms, i.e. patients
with irregular antibodies or antigen-
antibody complexes.
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